Literature DB >> 25763360

[Pharmacogenomic Biomarkers for the Prediction of Statin Efficacy and Safety].

Damiano Baldassarre1, Mauro Amato2, Beatrice Frigerio2, Gualtiero Columbo2, Philip F Binkley3, Saurabh R Pandey4, Adam M Suhy3, Katherine Hartmann3, Joseph P Kitzmiller3.   

Abstract

Entities:  

Year:  2013        PMID： 25763360      PMCID： PMC4353572     

Source DB:  PubMed          Journal:  G Ital Arterioscler        ISSN： 2240-4821


× No keyword cloud information.
  34 in total

1.  Comprehensive whole-genome and candidate gene analysis for response to statin therapy in the Treating to New Targets (TNT) cohort.

Authors:  John F Thompson; Craig L Hyde; Linda S Wood; Sara A Paciga; David A Hinds; David R Cox; G Kees Hovingh; John J P Kastelein
Journal:  Circ Cardiovasc Genet       Date:  2009-02-12

2.  Differential effect of the rs4149056 variant in SLCO1B1 on myopathy associated with simvastatin and atorvastatin.

Authors:  L R Brunham; P J Lansberg; L Zhang; F Miao; C Carter; G K Hovingh; H Visscher; J W Jukema; A F Stalenhoef; C J D Ross; B C Carleton; J J P Kastelein; M R Hayden
Journal:  Pharmacogenomics J       Date:  2011-01-18       Impact factor: 3.550

3.  Lack of effect of genetic polymorphisms of SLCO1B1 on the lipid-lowering response to pitavastatin in Chinese patients.

Authors:  Guo-ping Yang; Hong Yuan; Bin Tang; Wei Zhang; Lian-sheng Wang; Zhi-jun Huang; Dong-sheng Ou-Yang; Gui-xiang Zhang; Hong-hao Zhou
Journal:  Acta Pharmacol Sin       Date:  2010-02-08       Impact factor: 6.150

4.  Antibody levels correlate with creatine kinase levels and strength in anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy.

Authors:  Jessie L Werner; Lisa Christopher-Stine; Sharon R Ghazarian; Katherine S Pak; Jordan E Kus; Natalie R Daya; Thomas E Lloyd; Andrew L Mammen
Journal:  Arthritis Rheum       Date:  2012-12

5.  Pharmacogenetic study of statin therapy and cholesterol reduction.

Authors:  Daniel I Chasman; David Posada; Lakshman Subrahmanyan; Nancy R Cook; Vincent P Stanton; Paul M Ridker
Journal:  JAMA       Date:  2004-06-16       Impact factor: 56.272

6.  High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1).

Authors:  Mikko Niemi; Elke Schaeffeler; Thomas Lang; Martin F Fromm; Mikko Neuvonen; Carl Kyrklund; Janne T Backman; Reinhold Kerb; Matthias Schwab; Pertti J Neuvonen; Michel Eichelbaum; Kari T Kivistö
Journal:  Pharmacogenetics       Date:  2004-07

7.  CYP3A53A allele is associated with reduced lowering-lipid response to atorvastatin in individuals with hypercholesterolemia.

Authors:  Maria Alice V Willrich; Mario H Hirata; Fabiana D V Genvigir; Simone S Arazi; Ivanise M M Rebecchi; Alice C Rodrigues; Marcia M S Bernik; Egidio L Dorea; Marcelo C Bertolami; André A Faludi; Rosario D C Hirata
Journal:  Clin Chim Acta       Date:  2008-08-05       Impact factor: 3.786

8.  Regulation of plasma HDL cholesterol and subfraction distribution by genetic and environmental factors. Associations between the TaqI B RFLP in the CETP gene and smoking and obesity.

Authors:  D J Freeman; B A Griffin; A P Holmes; G M Lindsay; D Gaffney; C J Packard; J Shepherd
Journal:  Arterioscler Thromb       Date:  1994-03

Review 9.  Growing epidemic of coronary heart disease in low- and middle-income countries.

Authors:  Thomas A Gaziano; Asaf Bitton; Shuchi Anand; Shafika Abrahams-Gessel; Adrianna Murphy
Journal:  Curr Probl Cardiol       Date:  2010-02       Impact factor: 5.200

10.  Newly identified loci that influence lipid concentrations and risk of coronary artery disease.

Authors:  Cristen J Willer; Serena Sanna; Anne U Jackson; Angelo Scuteri; Lori L Bonnycastle; Robert Clarke; Simon C Heath; Nicholas J Timpson; Samer S Najjar; Heather M Stringham; James Strait; William L Duren; Andrea Maschio; Fabio Busonero; Antonella Mulas; Giuseppe Albai; Amy J Swift; Mario A Morken; Narisu Narisu; Derrick Bennett; Sarah Parish; Haiqing Shen; Pilar Galan; Pierre Meneton; Serge Hercberg; Diana Zelenika; Wei-Min Chen; Yun Li; Laura J Scott; Paul A Scheet; Jouko Sundvall; Richard M Watanabe; Ramaiah Nagaraja; Shah Ebrahim; Debbie A Lawlor; Yoav Ben-Shlomo; George Davey-Smith; Alan R Shuldiner; Rory Collins; Richard N Bergman; Manuela Uda; Jaakko Tuomilehto; Antonio Cao; Francis S Collins; Edward Lakatta; G Mark Lathrop; Michael Boehnke; David Schlessinger; Karen L Mohlke; Gonçalo R Abecasis
Journal:  Nat Genet       Date:  2008-01-13       Impact factor: 38.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.